Neumora Therapeutics, Inc. Common Stock
Status: Publicly traded
Direct answer
Neumora Therapeutics, Inc. Common Stock is publicly traded on NASDAQ under the ticker NMRA.
Neumora Therapeutics, Inc. is a specialized biopharmaceutical company progressing through clinical trials, dedicated to advancing therapies for a range of neurological, psychiatric, and neurodegenerative conditions. Its most advanced candidate, navacaprant (also known as NMRA-140), is a novel, once-daily oral kappa opioid receptor antagonist currently undergoing Phase 3 clinical trials for the management of major...
Can you invest in Neumora Therapeutics, Inc. Common Stock?
Yes. Neumora Therapeutics, Inc. Common Stock is publicly traded on NASDAQ under the ticker NMRA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Neumora Therapeutics, Inc. Common Stock
Detailed equity research is provided by MarketSnap.